Note 5 - Stockholders' Deficit (Details 2) - USD ($) |
3 Months Ended | |
|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
|
| Allocated Share-based Compensation Expense | $ 164,000 | $ 11,000 |
| Research and Development Expense [Member] | ||
| Allocated Share-based Compensation Expense | 15,000 | 8,000 |
| General and Administrative Expense [Member] | ||
| Allocated Share-based Compensation Expense | $ 149,000 | $ 3,000 |
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|